Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).

Krychtiuk, Konstantin A; Newby, L Kristin

Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).

Krychtiuk, Konstantin A; Newby, L Kristin.

Krychtiuk KA; Duke Clinical Research Institute, Durham, North Carolina, USA (K.A.K., L.K.N.).
Newby LK; Duke Clinical Research Institute, Durham, North Carolina, USA (K.A.K., L.K.N.).

Ann Intern Med ; 175(5): JC58, 2022 05.

Article in English | MEDLINE | ID: covidwho-1835631

ABSTRACT

ABSTRACT

SOURCE CITATION Husby A, Hansen JV, Fosbøl E, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis population based cohort study. BMJ. 2021;375e068665. 34916207.

Subject(s)

2019-nCoV Vaccine mRNA-1273; COVID-19; Myocarditis; 2019-nCoV Vaccine mRNA-1273/adverse effects; COVID-19/epidemiology; COVID-19/prevention & control; Cohort Studies; Humans; Myocarditis/chemically induced; Myocarditis/epidemiology; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / 2019-nCoV Vaccine mRNA-1273 / Myocarditis Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Ann Intern Med Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google